222 related articles for article (PubMed ID: 34280907)
1. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
[TBL] [Abstract][Full Text] [Related]
3. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
5. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence-powered microfluidics for nanomedicine and materials synthesis.
Liu L; Bi M; Wang Y; Liu J; Jiang X; Xu Z; Zhang X
Nanoscale; 2021 Dec; 13(46):19352-19366. PubMed ID: 34812823
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases.
Bakrania A; Joshi N; Zhao X; Zheng G; Bhat M
Pharmacol Res; 2023 Mar; 189():106706. PubMed ID: 36813095
[TBL] [Abstract][Full Text] [Related]
9. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine.
Dzobo K; Adotey S; Thomford NE; Dzobo W
OMICS; 2020 May; 24(5):247-263. PubMed ID: 31313972
[TBL] [Abstract][Full Text] [Related]
10. Current understanding of biological interactions and processing of DNA origami nanostructures: Role of machine learning and implications in drug delivery.
Singh M; Sharma D; Garg M; Kumar A; Baliyan A; Rani R; Kumar V
Biotechnol Adv; 2022 Dec; 61():108052. PubMed ID: 36307050
[TBL] [Abstract][Full Text] [Related]
11. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
Mozafari N; Mozafari N; Dehshahri A; Azadi A
Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
[TBL] [Abstract][Full Text] [Related]
12. Inorganic nanomaterials with rapid clearance for biomedical applications.
Wang X; Zhong X; Li J; Liu Z; Cheng L
Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice.
Mursch-Edlmayr AS; Ng WS; Diniz-Filho A; Sousa DC; Arnold L; Schlenker MB; Duenas-Angeles K; Keane PA; Crowston JG; Jayaram H
Transl Vis Sci Technol; 2020 Oct; 9(2):55. PubMed ID: 33117612
[TBL] [Abstract][Full Text] [Related]
14. A machine learning approach to identify clinical trials involving nanodrugs and nanodevices from ClinicalTrials.gov.
de la Iglesia D; García-Remesal M; Anguita A; Muñoz-Mármol M; Kulikowski C; Maojo V
PLoS One; 2014; 9(10):e110331. PubMed ID: 25347075
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial Nano-Bio Interfaces.
Cai P; Zhang X; Wang M; Wu YL; Chen X
ACS Nano; 2018 Jun; 12(6):5078-5084. PubMed ID: 29883094
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence in nanomedicine.
Ho D; Wang P; Kee T
Nanoscale Horiz; 2019 Mar; 4(2):365-377. PubMed ID: 32254089
[TBL] [Abstract][Full Text] [Related]
17. Merging data curation and machine learning to improve nanomedicines.
Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence in reproductive medicine.
Wang R; Pan W; Jin L; Li Y; Geng Y; Gao C; Chen G; Wang H; Ma D; Liao S
Reproduction; 2019 Oct; 158(4):R139-R154. PubMed ID: 30970326
[TBL] [Abstract][Full Text] [Related]
19. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
Chen Y; Wu Y; Sun B; Liu S; Liu H
Small; 2017 Mar; 13(10):. PubMed ID: 28075057
[TBL] [Abstract][Full Text] [Related]
20. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
